Distinguishable effects of Presenilin-1 and APP717 mutations on amyloid plaque deposition

Neurobiology of Aging

Volumn 22, Issue 3, 2001, Pages 367-376

  Ishii, Kazuhiro ^a,b   Lippa, Carol ^c   Tomiyama, Takami ^a,d   Miyatake, Fumiko ^a,b   Ozawa, Kazuharu ^a   Tamaoka, Akira ^b   Hasegawa, Takashi ^e   Fraser, Paul E ^f   Shoji, Shin'ichi ^b   Nee, Linda E ^g   Pollen, Dan A ^h   St George Hyslop, Peter H ^f   Ii, Kunio ^e   Ohtake, Toshiyuki ⁱ   Kalaria, Rajesh N ^j   Rossor, Martin N ^k   Lantos, Peter L ^l   Cairns, Nigel J ^l   Farrer, Lindsay A ^m   Mori, Hiroshi ^a,d  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e UNIVERSITY OF TOKUSHIMA   (Japan)

^f UNIVERSITY OF TORONTO   (Canada)

^g NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^h UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

ⁱ TOKYO METROPOLITAN NEUROLOGICAL HOSPITAL   (Japan)

^j CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^l KING'S COLLEGE LONDON   (United Kingdom)

^m BOSTON UNIVERSITY   (United States)

more..

Author keywords

A ; Aging; Alzheimer's disease; APOE; APP (amyloid precursor protein); Immunohistochemistry; Plaque; Presenilin 1

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; PRESENILIN 1;

ALZHEIMER DISEASE; ANALYTIC METHOD; ARTICLE; CELL DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; GENE MUTATION; GENOTYPE; HUMAN; HUMAN TISSUE; MALE; ONSET AGE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SENILE PLAQUE; SEQUENCE ANALYSIS;

ADULT; AGE OF ONSET; AGED; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; APOLIPOPROTEINS E; CELL COUNT; FEMALE; GENOTYPE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; MUTATION, MISSENSE; PEPTIDE FRAGMENTS; PRESENILIN-1; SENILE PLAQUES;

EID: 0034986571     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(01)00216-0     Document Type: Article

References (73)

1. Presenilin 1 protein directly interacts with Bcl-2
2. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins
3. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice
4. Applications of multivariate analysis of variance to repeated measures experiments
5. Alzheimer's Aβ(1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells
6. A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain
7. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein
8. Phosphorylation, subcellular localization, and membrane orientation of the Alzheimer's disease-associated presenilins
9. Increased amyloid-β42 (43) in brains of mice expressing mutant presenilin 1
10. Demence presenile d'Alzheimer transmise dans une famille etendue
11. Clinicopathological features of familial Alzheimer's disease with the M139V mutation in the presenilin 1 gene
12. Aβ peptide length and apolipoprotein E genotype in Alzheimer's disease
13. Segregation of a missene mutation in the amyloid precursor protein gene with familial Alzheimer's disease
14. A novel presenilin-1 mutation: Increased β-amyloid and neurofibrillary changes
15. Familial Alzheimer's disease in two kindreds of the same geographic and ethnic origin
16. Chemical characterization of Aβ 17-42 peptide, a component of diffuse amyloid deposits of Alzheimer disease
17. Amyloid β protein (Aβ) in Alzheimer's disease brain
18. Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptides
19. Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease
20. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI
21. Complete analysis of the presenilin 1 gene in early onset Alzheimer's disease
22. The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolution
23. Presenilin 1 suppresses the function of c-Jun homodimers via interaction with QM/Jif-1
24. Increased Aβ42 (43)-plaque deposition in early-onset familial Alzheimer's disease brains with the deletion of exon 9 and the missense point mutation (H163R) in the PS-1 gene
25. Aβ1-40 but not Aβ1-42 levels in cortex correlate with apolipoprotein E e4 allele dosage in sporadic Alzheimer's disease
26. Amyloid β protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in Down syndrome
27. Seeding "one-dimensional crystallization" of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie?
28. Three different mutations of presenilin 1 gene in early-onset Alzheimer's disease families
29. The precursor of Alzheimers disease amyloid A4 protein resembles a cell-surface receptor
30. Familial Alzheimer's disease. A pedigree with a missense mutation in the amyloid precursor protein gene (amyloid precursor protein 717 valine-glycine)
31. Amyloid precursor protein mutation causes Alzheimer's disease in Swedish family
32. Lewy bodies in the brains of two members of a family with the 717 (val-ile) mutation of the amyloid precursor protein
33. The E280A presenilin 1 Alzheimer mutation produces increased Aβ42 deposition and severe cerebellar pathology
34. A familial Alzheimer's disease locus on chromosome 1
35. Mutation of a putative sperm membrane protein in caenorhabditis elegans prevents sperm differentiation but not its associated meiotic divisions
36. Familial and sporadic Alzheimer's disease: Neuropathology cannot exclude a final common pathway
37. Predominant deposition of amyloid-β42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene
38. Amyloid β protein (Aβ) deposition in chromosome 14-linked Alzheimer's disease: Predominance of Aβ 42(43)
39. Alzheimer's presenile dementia, senile dementia of Alzheimer type and down's syndrome in middle age form an age related continuum of pathological changes
40. High levels of amyloid-beta protein from S182 (Glu246) familial Alzheimer's cells
41. Mass spectrometry of purified amyloid β protein in Alzheimer's disease
42. Clinical comparison of Alzheimer's disease in pedigrees with the codon 717 val-ile mutation in amyloid precursor protein gene
43. A locus for familial early-onset Alzheimer's disease on the long-arm of chromosome 14 proximal to the alpha 1 antichymotrypsin gene
44. A family with histologically confirmed Alzheimer's disease
45. A mutation in the Alzheimer's disease destroying a splice acceptor site in the presenilin 1 gene
46. Neurodegeneration induced by β-amyloid peptides in vitro: The role of peptide assembly state
47. Enhancer function and novel DNA binding protein activity in the near upstream betaAPP gene promoter
48. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene
49. Chromosome 14 and late onset familial Alzheimer's disease
50. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14
51. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
52. Endogenous presenilin 1 redistributes to the surface of lamellipodia upon adhesion of Jurkat cells to a collagen matrix
53. Amyloid β-protein and the genetics of Alzheimer's disease
54. The role of APP processing and trafficking pathways in the formation of amyloid beta-protein
55. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
56. Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14
57. Hippocampal lesions in dominantly inherited Alzheimer's disease
58. An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (βAPP717) mutants
59. Amyloid β protein 1-42/43 (Aβ1-42/43) in cerebellar diffuse plaques: Enzyme-linked immunosorbent assay and immunocytochemical study
60. APP717 missense mutation affects the ratio of amyloid β protein species (Aβ1-42/43 and Aβ1-40) in familial Alzheimer's disease brain
61. ApoE genotype does not modulate age of onset in families with chromosome 14 encoded Alzheimer's disease
62. Mapping of a gene predisposing to early-onset Alzheimer's disease to chromosome 14q24.3
63. The Alzheimer's disease-associated presenilins are differentially phosphorylated proteins located predominantly within the endoplasmic reticulum
64. Formation of stable complexes between two Alzheimer's disease gene products: Presenilin-2 and beta-amyloid precursor protein
65. Alzheimer's disease: Evidence for susceptibility loci on chromosome 6 and 14
66. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity
67. Interaction between amyloid precursor protein and presenilins in mammalian cells; implications for the pathogenesis of Alzheimer disease
68. Identification of a novel PSD-95/Dlg/ZO-1 (PDZ)-like protein interacting with the C terminus of presenilin-1
69. Neurogenic phenotypes and altered Notch processing in Drosophila Presenilin mutants
70. Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and beta APP processing
71. Evidence that Aβ42 is the real culprit in Alzheimer's disease
72. Presenilin-1 interaction in the brain with a novel member of the Armadillo family